SideBySideMeds
This page contains affiliate links. We may earn a commission if you sign up through them, at no cost to you. All recommendations are independent.
August 18, 2026 · Side-by-side comparison authority

Wegovy vs Saxenda: The Novo Nordisk Weight-Loss Comparison

Both Wegovy and Saxenda are Novo Nordisk GLP-1s approved for chronic weight management, but they use different molecules and have very different clinical profiles. Here's the side-by-side.

The Molecule Comparison

FeatureWegovySaxenda
MoleculeSemaglutideLiraglutide
FrequencyWeekly injectionDaily injection
Approval year (weight)20212014
Approx trial weight loss~15% at 68 weeks~8% at 56 weeks
Cash-pay pricing~$199-$349 (NovoCare)Cash market varies
Generic statusNoGeneric available (2025)

Sesame Care

Brand-name pathways

Marketplace for brand-name FDA-approved GLP-1 only.

  • Brand-name only
  • Direct consult marketplace
  • Cash-pay clarity
Check Latest Pricing

Why Wegovy Superseded Saxenda

Wegovy produces meaningfully greater weight loss than Saxenda at their respective approved doses, uses weekly injection instead of daily, and has broader indication expansion including CV outcomes. For most patients starting GLP-1 therapy for weight management in 2026, Wegovy is the more effective and more convenient option.

Found Health

$100 off promo

Brand-name GLP-1 access with coaching layer.

  • Brand-name focus
  • Coaching + accountability
  • Insurance-coordinated
Check Latest Pricing

Where Saxenda Still Has a Role

Saxenda retains some role in patients who: don't tolerate semaglutide but tolerate liraglutide, have insurance coverage for Saxenda but not Wegovy, or benefit from daily dosing for specific reasons. The 2025 generic liraglutide launch has made Saxenda a lower-cost option for patients able to access the generic formulation.

Oak Weight Loss

GLP-1 program

Telehealth program with compounded GLP-1 access.

  • Compounded GLP-1
  • Standard intake
  • Membership pricing
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

For Patients on Saxenda Considering Wegovy

Switching from Saxenda to Wegovy is generally straightforward — both target the GLP-1 receptor and cross-tolerance is common. Most prescribers would use a re-titration approach starting at Wegovy's low dose rather than converting directly to a maintenance dose. Expect a titration period even if you've been on maximum Saxenda dose.

Embody

Injectable semaglutide, $400 CPA tier

Injectable semaglutide only — lead compounded option.

  • Injectable semaglutide focus
  • Standard titration
  • Direct pharmacy shipping
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Wellorithm

Sema ~$147/mo, tirz ~$249/mo

Compounded GLP-1 with dose-tier pricing.

  • Sema and tirz options
  • Tier pricing by dose
  • Verify at intake
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

The Simple Answer

If your prescriber is starting you on GLP-1 therapy for weight management in 2026 and Wegovy is accessible and affordable to you, it's usually the more effective choice. Saxenda remains a legitimate alternative when Wegovy isn't accessible for cost, coverage, or tolerance reasons.

MadeMed

Compounded GLP-1 options

Independent compounder — sema, tirz, and oral formats.

  • Compounded sema/tirz
  • Oral tirz $167-229
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Telos Rx

Compounded tirzepatide

Compounded tirzepatide via direct pharmacy.

  • Compounded tirzepatide
  • Direct-link intake
  • Verify pricing
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Where to Start

Embody

Injectable semaglutide, $400 CPA tier

Injectable semaglutide only — lead compounded option.

  • Injectable semaglutide focus
  • Standard titration
  • Direct pharmacy shipping
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Wellorithm

Sema ~$147/mo, tirz ~$249/mo

Compounded GLP-1 with dose-tier pricing.

  • Sema and tirz options
  • Tier pricing by dose
  • Verify at intake
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

MadeMed

Compounded GLP-1 options

Independent compounder — sema, tirz, and oral formats.

  • Compounded sema/tirz
  • Oral tirz $167-229
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing
Medical & editorial disclaimer. This article is for informational purposes only and is not medical advice. GLP-1 medications require prescriber evaluation. Compounded GLP-1 medications are not FDA-approved. Talk to a licensed clinician before starting, stopping, or changing any prescription. Provider pricing, availability, and program terms change frequently — verify current details on each provider's site before making a decision. Some links are affiliate links, which means we may earn a commission if you sign up; this does not change our recommendations or the price you pay.